Global Collagen And HA Based Biomaterial Market Size By Type (Urinary Incontinence, Corneal Shields, Facial Aesthetic Dermal Fillers, Wound Dressings), By Application (Cosmetology, Wound Care), By Geographic Scope And Forecast

Collagen And HA Based Biomaterial Market Size And Forecast

Collagen And HA Based Biomaterial Market size was valued at USD 4.07 Billion in 2020 and is projected to reach USD 4.94 Billion by 2028, growing at a CAGR of 2.50% from 2021 to 2028.

New collagen-based products being introduced, an increase in joint diseases, successful wound healing, and the growing use of collagen in dermatology, rheumatology, and ophthalmology are some of the reasons propelling the Collagen And HA Based Biomaterial Market forward. The Global Collagen And HA Based Biomaterial Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Collagen And HA Based Biomaterial Market Definition

Any materials, surface, or construct that interacts with biological processes is referred to as a biomaterial. Biomaterials can be found in nature or created in the lab with the use of metallic components, polymers, ceramics, and composite materials. Biomaterial-based medical devices are frequently utilized to replace or augment natural functions. Heart valves, hip replacements, and materials used in dentistry and surgery are just a few examples. Collagen is a protein produced by the dermis, the deepest layer of the skin, and hyaluronic acid, which is found in skin, joints, and eye sockets, aids in the retention of collagen and improves skin texture. Collagen-based biomaterials are now widely used in tissue engineering. In nature, collagen is biodegradable and biocompatible. Biomaterials based on collagen and HA have lately been employed to improve facial appearances.

Biomaterials are one of the most important materials in the pharmaceutical and healthcare industries. Because of their extensive availability, biodegradability, and biocompatibility, collagen and HA-based biomaterials are commonly employed in tissue engineering. Regenerative medicine, the food business, personal healthcare, and the development of prosthetics could all benefit from collagen and HA-based biomaterials. Rapid technical breakthroughs, major new product launches by industry players, an increase in cosmetic operations, and the benefits provided by collagen and HA-based biomaterials are expected to propel the worldwide Collagen And HA Based Biomaterial Market forward over the forecast period.

Global Collagen And HA Based Biomaterial Market Overview

The expansion of the Collagen and HA Based Biomaterial Market is being fueled by an increase in people’s disposable money and a desire for aesthetic procedures all over the world. New collagen-based products being introduced, an increase in joint diseases, successful wound healing, and the growing use of collagen in dermatology, rheumatology, and ophthalmology are some of the reasons propelling the Collagen And HA Based Biomaterial Market forward. Nestlé Skin Health’s dermal filler Restylane Lyft was just authorized by the FDA for cosmetic and aesthetic uses. The fundamental issue faced by companies is that sterilizing collagen without changing its structure is not conceivable. Due to the global pandemic, Collagen and HA-based Biomaterials makers are concentrating their efforts on important Collagen and HA-based Biomaterials, such as ventilators and diagnostics. Nonetheless, in the coming year, the market for collagen and HA-based biomaterials will benefit from the optimization of collagen material for medical usage.

However, the supply chain has been disrupted as a result of precautionary actions implemented by governments in various countries. As a result, there may be a device shortage in some areas. On the other hand, the Food and Drug Administration (FDA) issued COVID-19 instructions to medical device makers, instructing them to notify the agency of any changes that may influence the availability of their goods. Over the last few months, almost every industry in the globe has suffered a setback. This can be ascribed to severe disruptions in their respective manufacturing and supply-chain operations as a result of various precautionary lockdowns and other limitations imposed by governments all over the world. The same may be said for the global market for Collagen and HA-based Biomaterials. Furthermore, consumer demand has decreased as people are now more focused on removing non-essential expenses from their budgets since the general economic situation of most people has been badly impacted by the outbreak.

In recent years, facial cosmetic treatments have emphasized high-quality results with minimal stages. While collagen and hyaluronic acid (HA)-based biomaterials have been utilized for years to improve wound healing and cosmetic procedures, there is currently a flurry of activity focused on improving patient outcomes. Due to technical developments and the introduction of new and effective treatments, the number of cosmetic procedures performed around the world has increased in recent years. Nonetheless, chronic diseases such as diabetes, degenerative joint problems, and skin infections are increasingly being treated using collagen and hyaluronic acid-based biomaterials, which is a major driver of the global Collagen And HA Based Biomaterial Market. Collagen has some benefits, including the capacity to maintain stability while stimulating tissue growth, which is being used by manufacturers to improve orthopedic and wound care treatment choices.

Manufacturers are also increasingly focused on the medical demands of patients with joint and mobility-related difficulties, which are expected to become more common in the future, putting a considerable financial strain on the global economy. Religious and cultural views are increasingly hindering the acceptability and adoption of collagen and hyaluronic acid-based biomaterials as animal-derived elements become more widely used in healthcare, particularly in the case of collagen sources. Pigs and cows are abundant sources of collagen, but the use of products derived from these sources is troublesome in many geographical markets, limiting the worldwide Collagen And HA Based Biomaterial Market growth.

Global Collagen And HA Based Biomaterial Market Segmentation Analysis

The Global Collagen And HA Based Biomaterial Market is Segmented on the basis of Type, Application, And Geography.

Collagen And HA Based Biomaterial Market, By Type

• Urinary Incontinence• Corneal Shields• Facial Aesthetic Dermal Fillers• Wound Dressings• Others

Based on Type, The market is segmented into Urinary Incontinence, Corneal Shields, Facial Aesthetic Dermal Fillers, Wound Dressings, and Others.

Collagen And HA Based Biomaterial Market, By Application

• Cosmetology• Wound Care• Others

Based on Application, The market is segmented into Cosmetology, Wound Care, and Others.

Collagen And HA Based Biomaterial Market, By Geography

• North America• Europe• Asia Pacific• Rest of the world

Based on Regional Analysis, The Global Collagen And HA Based Biomaterial Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. Geographically, the Collagen And HA Based Biomaterial Market in North America is the most developed, followed by the European market. The rising prevalence of various diseases, the development of new and technologically advanced products, the use of single-injection Visco supplement products, and the increasing need of individuals to stay fit and healthy as they age are some of the major factors driving this market’s growth in these regions. The Asia-Pacific region is one of the most promising markets for collagen and HA-based biomaterials. This area is rapidly expanding and developing.

Key Players

The “Global Collagen And HA Based Biomaterial Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Galderma Laboratories L.P., Collagen Solutions Plc, Anika Therapeutics, Inc., Abbott Laboratories, Allergan plc, Johnson & Johnson Services, Inc., Sanofi, Bausch Health Companies Inc., and BioCell Technology LLC. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

Partnerships, Collaborations and Agreements

• In February 2021, CollPlant Biotechnologies (NASDAQCLGN) today announced it has entered into a worldwide exclusive development and commercialization agreement for dermal and soft tissue filler products with Allergan Aesthetics, an AbbVie company.

Mergers and Acquisitions

• In October 2020, Rosen’s diversified, Inc., acquired Collagen solutions, which is headquartered in Glasgow, Scotland, and is a leading contract developer and manufacturer of regenerative medical devices using collagen and tissue-based biomaterials.

• In February 2020, – Anika Therapeutics, Inc., a global, integrated joint preservation and regenerative therapies company with products leveraging its proprietary hyaluronic acid (HA) technology platform, announced its acquisition of Arthrosurface, a leading, privately-held provider of joint surface and preservation solutions for active patients.

Product Launches and Product Expansions

• In April 2021, Allergan Aesthetics, an AbbVie company (NYSEABBV), announced the launch of SkinMedica® Neck Correct Cream, the first product from the professional-grade skincare line formulated to address the specific biology of the skin on the neck and décolleté area. SkinMedica® Neck Correct Cream was designed to prevent the early signs as well as treat the visible appearance of moderate to severe neck aging.

• In February 2021, Galderma announces that the U.S. Food and Drug Administration (FDA) has approved Restylane® Defyne for the augmentation and correction of mild to moderate chin retrusion for adults over the age of 21. Restylane Defyne is a hyaluronic acid (HA) dermal filler that was first approved in 2016 by the FDA for mid-to-deep injection into the facial tissue for the correction of moderate to severe deep facial wrinkles and folds, such as nasolabial folds, in subjects over age 21.

Report Scope

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.